Ret Proto-Oncogene Antikörper
-
- Target Alle Ret Proto-Oncogene (RET) Antikörper anzeigen
- Ret Proto-Oncogene (RET)
-
Reaktivität
- Human
-
Wirt
-
Huhn
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Ret Proto-Oncogene Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF)
- Spezifität
- The RET proto-oncogeneis a receptor tyrosine kinase for members of the glial cell line-derivedneurotrophic factor family of extracellular signalling molecules
- Produktmerkmale
- Mono- and polyclonal antibodies to human growth factors and neural growth factor receptors.
- Aufreinigung
- RET affinity purified
- Isotyp
- IgY
- Top Product
- Discover our top product RET Primärantikörper
-
-
- Applikationshinweise
- Westernimmunoblotting, recommended dilution 1:5 000 to 1:10 000, ELISA: 1:80 000 to 1:120000, IF 1:250 to 1:500. Polyclonal antibody working titer has to be established practically for each particularantigen and assay format
- Kommentare
-
Synonym: Proto-oncogene tyrosine-protein kinase receptorRet, Cadherin family member 12, Proto-oncogene c-Ret
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/ml
- Buffer
- Concentrated ammonium sulphate in PBS pH 7.4
- Handhabung
- As product is (NH4)2SO4 precipitate, mix well by pipetting or vortexing prior use
- Lagerung
- 4 °C
- Informationen zur Lagerung
- This product is shipped in non-frozen liquid form in ambient conditions
-
- Target
- Ret Proto-Oncogene (RET)
- Andere Bezeichnung
- RET (RET Produkte)
- Hintergrund
- Recombinant His-tagged extracellular fragment of humanRET protein produced using CHO-based cell line. The extracellular fragment of hRET was expressed andsecreted to the cell culture supernatant. Protein was purified by Ni-affinitychromatography following gel-filtration from cell culture supernatant
- UniProt
- P07949
- Pathways
- RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
-